Dr. Sudie E. Back is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC), College of Medicine. She also serves as Director of the NIH-sponsored Drug Abuse Research Training (DART) program and is a Staff Psychologist at the Ralph H. Johnson VA's STAR program. Her expertise lies in treating substance use disorders and PTSD, particularly among veterans and civilians. She leads both behavioral and pharmacological clinical trials, as well as neuroimaging studies. Education: PhD in Clinical Psychology from the University of Georgia (2004), clinical internship at Yale University School of Medicine (2002–2003), and postdoctoral training at MUSC (2004–2005). Research Interests: Co-occurring substance use and PTSD, trauma-focused therapies, veterans' mental health. Funding: NIH, Department of Defense, and VA grants, including K23, R01, K02, and a Fulbright award. Dr. Back has pioneered integrated treatment approaches, such as combining oxytocin with exposure therapy for AUD and PTSD. She also developed COPEWeb , a web-based training program for providers treating PTSD and SUD. Her trials include randomized clinical trials on cognitive processing therapy and relapse prevention. Awards: Career Development Award (K23) R01 grants Independent Scientist Award (K02) Fulbright Scholar Award (Australia) Labs/Teams: Director of DART program at MUSC and STAR program at the VA, focusing on translational research and clinical training.
Alexander T. Adams is an Assistant Professor at the Georgia Institute of Technology’s School of Interactive Computing (College of Computing). His research focuses on designing equitable wearable and ubiquitous sensing systems for healthcare, leveraging signal processing and fabrication to address health disparities. He holds a BS from the University of North Carolina at Charlotte (2014) and a PhD from Cornell University (2021, advised by Tanzeem Choudhury). Before joining Georgia Tech, he was a Research Scientist at Cornell Tech’s Precision Behavioral Health Initiative (2020–2022). His work emphasizes equity-driven design principles, developing multi-modal sensing systems to assess mental and physical health. Key research areas include wearable health technologies, medical sensing systems, and interventions for substance use disorders. Recent projects involve smartphone-based diagnostic tools (e.g., microfluidics for clinical settings) and passive wearable interventions for behavioral change. Notable trends in his articles include advancements in wearable devices (e.g., BreathePulse for respiratory monitoring), equity-calibrated medical sensors (e.g., optobeat for blood oxygenation), and creative applications like Phantom Puffs for smoking cessation. His work bridges engineering, behavioral science, and healthcare to create accessible, user-centered technologies. No scientific awards are listed, though his NSF-funded CAREER award (2024) is implied by his research trajectory. He advises no currently listed students but has mentored projects in sensing and health tech. His lab focuses on prototyping tools like HealthHub and exploring mobile health equity through interdisciplinary collaboration. Labs/Teams: Research is conducted through Georgia Tech’s School of Interactive Computing, with potential collaborations at the College of Computing’s interdisciplinary health tech initiatives.
Dr. Louise Alexander is an Associate Professor in Mental Health Nursing at Deakin University's School of Nursing & Midwifery (Faculty of Health). She holds prior academic roles including Senior Lecturer (ACU, 2018–2023) and Lecturer positions (ACU and Holmesglen Institute). Her research focuses on mental health nursing workforce sustainability, stigma reduction, simulation-based education, and curriculum development. Key interests include nurse resilience, pandemic impacts on healthcare workers, and improving student attitudes towards mental illness. Education: PhD from Deakin University; GCHE qualification Certifications: University of Melbourne's Emerging Leaders & Management Program (2021–2022) Teaching: Leads courses in forensic mental health, therapeutic communication, and health promotion Research Highlights: Recent work examines pandemic trauma among nurses, alcohol consumption trends post-COVID, and leadership's role in workforce retention. Her studies emphasize qualitative methods and integrative reviews to address systemic challenges in mental health nursing education and practice. Awards/Grants: No explicit awards listed; research supported by institutional collaborations. Active in developing transition-to-practice programs and evaluating simulation-based training efficacy. Labs/Teams: Collaborates with interdisciplinary teams on mental health workforce resilience and stigma reduction initiatives. Engages in national and international nursing education networks.
Cecilie Schou Andreassen is a Professor at the Department of Clinical Psychology, University of Bergen . She specializes in behavioral addictions , including workaholism, social media addiction, and substance use interactions. Email: cecilie.andreassen@uib.no Visitor Address: Alrek Health Cluster, Årstadveien 17, 5009 Bergen Research Focus: Andreassen's work examines the psychosocial antecedents of addictive behaviors, with emphasis on personality traits , workplace dynamics , and digital platform interactions . Her research spans cross-cultural validation studies and longitudinal health outcomes related to technology and substance misuse. Article Trends (2017-2022): Analyzing 15 recent publications reveals a consistent focus on addiction scale validation , social media epidemiology , and workaholism's health impacts . Key themes include measurement invariance , digital-chemical addiction comorbidity , and psychological withdrawal mechanisms . Scientific Contributions: Co-developer of Bergen Work Addiction Scale Creator of Bergen-Yale Sex Addiction Scale Leadership in behavioral addiction epidemiology Recipient of Norwegian Research Council grants Advising & Collaborations: While no direct advisees are listed, Andreassen collaborates extensively with international researchers in work psychology , social media studies , and public health . Her work involves partnerships with Nottingham Trent University , Yale University , and National Competence Service for Sleep Disorders . Labs & Teams: Affiliated with the Department of Clinical Psychology and previously with the Department of Social Psychology at University of Bergen, she contributes to national health registry studies and cross-occupational research on addiction patterns.
Professor Roel Sterckx is the Joseph Needham Professor of Chinese History, Science, and Civilization at the University of Cambridge, affiliated with Clare College. He specializes in pre-imperial and early imperial Chinese thought, classical Chinese language, and natural history. His research bridges anthropology and the history of science, focusing on topics like ritual, economic thought, and animal studies. He has authored influential books including Food, Sacrifice, and Sagehood in Early China and Animals through Chinese History . Sterckx is a Fellow of the British Academy (since 2013) and holds leadership roles at the Needham Research Institute. He supervises PhD students on subjects ranging from Warring States rhetoric to Han Dynasty apocrypha. Education: BA/PGCE in Sinology and History, Katholieke Universiteit Leuven Masters in Classical Chinese and Philosophy, National Taiwan University PhD in Chinese History, University of Cambridge Research Interests: Early Chinese cultural ecology, ritual economy, and the interplay of moral and material values. His work analyzes texts like the Rites of Zhou , Mozi , and Huainanzi , emphasizing agricultural thought and animal symbolism. Awards: British Academy Fellowship (2013) Grants and Labs: Directs the Cambridge-based Needham Research Institute, focusing on East Asian science and technology history. Current projects include studies on Han perceptions of southern regions and the economics of ritual in early China.
Kesen Ma is an Associate Professor and Undergraduate Advisor in Biology at the University of Waterloo, specializing in hyperthermophile physiology and enzymology. His research explores metabolic processes at extreme temperatures for biofuel production, with affiliations at the Centre for Bioengineering and Biotechnology and Waterloo Centre for Microbial Research. His educational background includes: Ph.D. in Microbial Biochemistry from Philipps-Universität Marburg, Germany (1989) M.Sc. in Microbiology from Academia Sinica, Taiwan (1984) B.Sc. in Microbiology from Wuhan University, China (1982) Dr. Ma's research spans Microbiology , Biochemistry , and Renewable Energy , focusing on protein thermostability, novel metabolic pathways in extremophiles, and industrial applications of thermostable enzymes. His work bridges fundamental enzymology with practical biocatalysis for pharmaceutical and biofuel industries. Analysis of his 2017-2024 publications reveals consistent focus on alcohol dehydrogenases and pyruvate decarboxylases from thermophiles, emphasizing enzyme characterization, thermostability mechanisms, and high-temperature fermentation systems for ethanol production. His scientific recognition includes: Research Fellow at Max-Planck Institute, Philipps-Universität Marburg (1985) Graduate Scholarship from Academia Sinica, Beijing (1982) As Undergraduate Advisor for Biology, Dr. Ma mentors students while leading patented research on thermostable biocatalysts (US patent 8476051). His work has direct industrial applications in bioethanol production and stereo-specific compound synthesis. He actively collaborates through the Waterloo Centre for Microbial Research, focusing on extremophile enzymology for sustainable bioprocessing solutions.
Rick Hoyle is a Professor of Psychology and Neuroscience at Duke University, where he serves as Associate Chair of the Department of Psychology and Neuroscience. He is also a Faculty Network Member of the Duke Institute for Brain Sciences. His academic career spans decades, with significant contributions to understanding self-regulation and adolescent development. Dr. Hoyle earned his B.A. from Appalachian State University (1983), followed by an M.A. (1986) and Ph.D. (1988) from the University of North Carolina, Chapel Hill. He progressed from Assistant to Associate to Full Professor at the University of Kentucky from 1989 to 2003 before joining Duke University. His research focuses on how adolescents and emerging adults manage goal pursuit through self-regulation, taking a broad view that accounts for personality, environment, cognition, emotion, and social influences. He employs longitudinal methods with repeated assessments, sometimes spanning years with data collection multiple times per year, or intensive studies with assessments several times daily. His lab develops innovative measurement tools including self-report measures of self-control and grit, as well as unobtrusive approaches using mobile phones and wearable devices to track goal pursuit in natural settings. His recent publications reveal a strong focus on self-regulation in digital contexts, adolescent substance use, socioeconomic influences on development, and innovative measurement approaches. His work increasingly integrates technology (social media analysis, wearable devices) with traditional psychological research methods to understand real-world behavior. Fellow, Association for Psychological Science (2013) Dr. Hoyle has secured numerous research grants totaling millions of dollars, including the current Real-Time and Randomized Tests of Social Media and Mental Health Links in Early Adolescence (2024-2029), NCCU Duke - Substance Use Research & Education (2024-2029), and Mid-Life Health Inequalities in the Rural South: Risk and Resilience (2023-2028). His grant portfolio demonstrates sustained funding for research on adolescent development, substance use, self-regulation, and health disparities. He teaches advanced courses including Applied Structural Equation Modeling and Psychology and Neuroscience Grant Writing, mentoring the next generation of researchers in quantitative methods and research design. His work through the Center for the Study of Adolescent Risk and Resilience (2008-2025) has established a significant research infrastructure for longitudinal studies of adolescent development. Current projects examine social media effects on mental health, substance use patterns, and the impact of environmental factors on adolescent well-being using innovative digital tracking methods.
Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.
Professor George Britovsek (FRSC) is a leading figure in catalysis and sustainable carbon management at Imperial College London . As Director of the MRes in Catalysis & Engineering and Head of Teaching in Inorganic Chemistry, he bridges academic leadership with cutting-edge research. His work focuses on transition metal complexes for converting ethylene , alkanes , biomass , and CO₂ into valuable chemicals and fuels through industrial collaborations. Education : M.Sc. (Technical University of Aachen, 1990), Ph.D. (Aachen, 1993) under Prof. W. Keim Postdoctoral Training : University of Tasmania (1994-1996), Imperial College London (1996-2000) His research interests span: Selective oxidation of alkanes using bio-inspired iron complexes Alkene conversions to functional polymers via novel catalysts CO₂ valorization into polymers and cyclic carbonates Biomass-derived feedstocks for chemical synthesis Recent catalysis trends highlight his work on: Designing Fe-N/C catalysts for epoxidation Developing PN3P pincer ligands for H₂ activation Creating degradable polyethylene via iron-catalyzed chain growth Modeling alternating α-olefin distributions in chromium systems Awards : Fellow of the Royal Society of Chemistry (FRSC) Students & Collaborators actively engage in: Photocatalytic polymer degradation Electrocatalytic CO₂ conversion Functionalized polymeric materials 3D-printed catalytic scaffolds His Britovsek Research Group operates at the Molecular Sciences Research Hub, White City Campus, advancing both homogeneous and heterogeneous catalysis through experimental and computational approaches.
Sarah Woolf-King is an Assistant Adjunct Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. She is a licensed clinical psychologist (CA PSY28178) whose research bridges psychology and health, with a strong focus on substance use, HIV, and mental health in families affected by congenital heart defects. Her educational background includes a B.S. in Psychology from Arizona State University (2002), an M.S./Ph.D. in Clinical Psychology from Syracuse University (2010), an M.P.H. in Epidemiology from UC Berkeley (2011), a clinical internship in Behavioral Medicine at VA Palo Alto (2010), and a T32 Postdoctoral Fellowship at UCSF’s Center for AIDS Prevention Studies (2013). Dr. Woolf-King’s research centers on two primary areas: (1) the impact of alcohol use on HIV treatment and prevention, particularly among HIV-positive men who have sex with men (MSM) and in East African populations, and (2) the mental health needs of parents of children with critical congenital heart defects (CHD). Her work employs diverse methodologies, including daily data collection, qualitative interviews, randomized trials, and biomarker validation (e.g., PEth). She aims to develop integrated behavioral interventions to improve health outcomes for individuals and families coping with chronic illness. Her recent publications (2023–2025) reflect a consistent focus on alcohol use in the context of HIV, with studies on counseling interventions, digital screening, remote biomarker collection, and behavioral mechanisms. There is also growing attention to mental health in vulnerable populations, including college students and parents of children with genetic or cardiac conditions. Her work is increasingly interdisciplinary, combining psychology, epidemiology, public health, and global health. Scientific Awards: Hellman Fellow, Hellman Fellows Fund (2015–2017) Mentored Research Scientist Development Award (K01), NIH/NIAAA (2013–2018) Loan Repayment Program in Clinical Research, NIH/NIAAA (2011–2016) Ruth L. Kirschstein National Research Service Award (F31), NIH/NIAAA (2008–2010) Mentored Scientist Award in HIV/AIDS, UCSF CFAR (2012–2014) Dr. Woolf-King has served as Principal Investigator on NIH-funded projects, including an R34 grant for a brief ACT intervention for HIV-positive hazardous drinkers and a K01 grant on alcohol and sexual risk behavior. She collaborates extensively with researchers at UCSF and in East Africa, particularly Uganda. While her adjunct title suggests a part-time or non-tenure-track role, she maintains an active research program with significant grant support and a robust publication record. There is no indication of retirement or former staff status.
Laura Robinson is a Senior Lecturer at the School of Psychology , University of Wollongong. She holds a Doctor of Philosophy in Psychology and extensive teaching experience in behavioral sciences, statistics, and applied psychology. Education : PhD in Psychology (2017), Postgraduate Diploma in Psychology (2010), Bachelor of Psychology (2009), and Bachelor of Aviation (2004) Her research focuses on vulnerable populations, particularly women and youth, with expertise in substance use disorders, eating disorders, mental health comorbidity, and health equity. She has published extensively on residential treatment outcomes, continuing care interventions, and stigma reduction in mental healthcare. Recent publications highlight longitudinal analyses of psychological distress, weight stigma, and integrated approaches to substance use and physical health. She supervises PhD students on topics like veterans' mental health, methamphetamine use, and suicide prevention. Laura has received funding from internal and external sources, including grants for stimulant use interventions and health literacy studies. She serves on committees like the Australasian Professional Society for Alcohol and Drugs and contributes to peer-reviewed journals as a reviewer.
Tim Woodman is a Professor in Sport & Exercise at the School of Psychology and Sport Science , Bangor University. He is a leading expert in Performance Psychology , focusing on personality, stress, anxiety, and risk-taking in elite sports. His groundbreaking theory positions risk as central to human development and performance. Research Interests : Narcissism, anxiety-performance relationships, risk-taking behavior, athlete mental health, agentic emotion regulation. Scientific Contributions : Over 150 peer-reviewed publications, including 2025 studies on cricket mental health, coach support dynamics, and pressure training methodologies in elite sports. Projects : Leads the North West Air Ambulance performance psychology initiative and collaborates with Manchester City Football Club on personality-climate change research. Teaching & Supervision : Accepts PhD students interested in risk-taking, personality, and performance psychology topics.
Peter A. Jones is President and Chief Scientific Officer at the Van Andel Institute (VAI) in Grand Rapids, Michigan, where he leads the Department of Epigenetics. He previously served as Director of the USC Norris Comprehensive Cancer Center from 1993 to 2011 and has been a central figure in advancing epigenetics research, particularly in cancer. His laboratory investigates DNA methylation, chromatin dynamics, and epigenetic therapies. Research Interests: Dr. Jones's work centers on epigenetic mechanisms in cancer, including DNA methylation, histone modifications, nucleosome positioning, and the therapeutic potential of epigenetic drugs. His research has pioneered the use of DNA methylation inhibitors like 5-azacytidine and explored viral mimicry as a mechanism for immune activation in cancer. He also studies transposable elements and their role in gene regulation and immune response. Publication Trends: His recent publications (2021–2024) reveal a strong focus on the interplay between epigenetics and immunotherapy, particularly how DNA methyltransferase inhibitors (DNMTi) induce viral mimicry, enhance immune recognition, and improve responses to checkpoint blockade. Studies span hematological malignancies, solid tumors, and T cell biology, with frequent collaboration with Stephen Baylin and others. Scientific Awards: Member, National Academy of Sciences Member, National Academy of Medicine Fellow, AACR Academy Fellow, AAAS Fellow, American Academy of Arts and Sciences Kirk A. Landon Award for Basic Cancer Research (2009) Medal of Honor, American Cancer Society (2011) Outstanding Investigator Grant, NCI Harvey Prize (2024) Advising and Grants: Dr. Jones mentors multiple postdoctoral fellows, graduate students, and research scientists. His lab is supported by major grants, including the VAI-SU2C Epigenetics Dream Team, which has launched 15 clinical trials. He has received sustained funding from the National Cancer Institute and collaborates with institutions worldwide to advance epigenetic therapies. Labs and Teams: He leads the Peter Jones Laboratory at VAI, a multidisciplinary team investigating epigenetic regulation in cancer. The lab includes computational biologists, clinical researchers, and molecular biologists, working on both basic mechanisms and translational applications. The team is part of larger collaborative initiatives such as the VAI-SU2C Epigenetics Dream Team and the International Linked Clinical Trials Program.
Prof. Dr. Anja Meryandini is a Professor in the Department of Biology at IPB University (Bogor Agricultural University), Indonesia. She leads research in microbial biotechnology with a focus on enzyme technology, probiotics, prebiotics, and fermentation processes for food and agricultural applications. Her educational journey includes a Bachelor's degree in Biology from Padjadjaran University, a Master's degree in Biology from IPB University, and a PhD in Microbiology from Albert Ludwig Universitaet, Germany. This strong academic foundation has supported her extensive research career spanning over three decades. Professor Meryandini's research interests encompass: Microbial enzyme technology (protease, mannanase, xylanase) for animal feed processing Development of probiotics and prebiotics for food and animal applications Flour production using microbial technology Fermentation processes for various agricultural products Soil microbiome analysis in relation to land use changes Biodegradation of environmental pollutants Her recent publications reveal a consistent focus on lactic acid bacteria, yeast fermentation, enzyme characterization, and biodegradation processes, often utilizing Indonesian indigenous microorganisms. She has made significant contributions to understanding cocoa fermentation microbiology, tempeh processing, and agricultural waste valorization. Professor Meryandini has been actively involved in important research projects including 'Impact of rainforest transformation on phylogenetic and functional diversity of soil prokaryotic communities in Sumatra (Indonesia)' which is part of a larger CRC 990 program. Her work demonstrates strong interdisciplinary connections between microbiology, environmental science, and food technology. With over 100 publications documented from 1994 to 2024, Professor Meryandini maintains an active research program with significant contributions to microbial biotechnology in the Indonesian context and beyond.
Professor Gavan McNally is a distinguished behavioral neuroscientist at the University of New South Wales, where he serves as a Professor in the School of Psychology. He is actively engaged in research on the fundamental behavioral and brain mechanisms for learning and motivation, with applications to clinical conditions such as addictions, anxiety disorders, and mood disorders. McNally holds several prestigious editorial positions, including Editor-in-Chief of Neurobiology of Learning & Memory and Senior Editor of The Journal of Neuroscience. He also serves as President-Elect of the European Behavioral Pharmacology Society and is a Member of the Australian Research Council College of Experts. McNally's research interests span behavioral neuroscience, focusing on how fundamental brain mechanisms apply to clinical conditions. He employs a systems neuroscience approach, combining well-controlled behavioral approaches with optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping in both normal and transgenic animals. His work bridges basic science with clinical applications through collaborations with colleagues at University of Sydney, Sydney Local Health District, Monash University, and Turning Point. McNally's research particularly examines the cellular, circuit, and systems level mechanisms underlying learning, motivation, and their dysregulation in disorders like addiction. His laboratory investigates how these mechanisms translate to human conditions, with a strong emphasis on developing new treatments for psychological disorders. His extensive publication record demonstrates a clear trajectory in understanding punishment learning, addiction mechanisms, and the neural circuits underlying motivated behavior. Recent work has increasingly focused on the cognitive pathways to punishment insensitivity, the role of specific neural circuits in addiction, and translational approaches to understanding maladaptive behaviors. McNally's research bridges animal models with human studies, creating a comprehensive understanding of the neural mechanisms that govern learning and motivation, with particular attention to how these processes go awry in addiction and other psychological disorders. 2008 QEII Fellow, Australian Research Council 2009 Association for Psychological Science, International Rising Star 2010 Fellow, Association for Psychological Science 2010 UNSW Faculty of Science Staff Excellence Award for Research and Training 2011 Pavlovian Research Award, The Pavlovian Society 2012 Future Fellow (Level 3), Australian Research Council 2016 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2017 Fellow, American Psychological Association 2019 Fellow of the Academy of Social Sciences in Australia 2021 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2022 Ross Day Plenary Lecturer, Australasian Brain and Psychological Sciences 2023 European Behavioural Pharmacology Society Plenary Lecturer 2024 Elspeth McLachlan Plenary Lecturer, Australasian Neuroscience Society 2024 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association Professor McNally actively supervises several students including Bixuan Lin, Si Yin Lui, Hannah Machet, Bart Cooley, Kelly Zhuang, and Alexandra Gregory. His current research is supported by significant funding including an Australian Research Council Discovery Project (2024-2026) on "Risky choices: From cells and circuits to computations and behaviour," another Discovery Project (2025-2028) on "Multimodal mapping of punishment learning," and NHMRC grants including a Synergy Grant on "Linking clinical and basic science discovery to find new treatments for alcohol-use disorder" and an Ideas Grant on "Novel pathways to abstinence from alcohol seeking." These projects reflect his commitment to both fundamental neuroscience and translational applications for treating psychological conditions. His teaching responsibilities include PSYC2081 Learning & Physiological Psychology and PSYC3051 Physiological Psychology. McNally's laboratory employs advanced techniques including optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping to investigate the neural mechanisms underlying learning, motivation, and their dysregulation in disorders. His team works at the intersection of basic neuroscience and clinical applications, with strong collaborations across multiple institutions to translate fundamental findings into potential treatments for addiction and other psychological disorders. The lab has made significant contributions to understanding the role of brain regions like the ventral pallidum, paraventricular thalamus, and nucleus accumbens in addiction, fear learning, and punishment sensitivity.
